Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Laser hair removal is popular for long-term hair reduction but carries risks, requiring well-trained operators and better regulations, especially in South Africa.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Post-finasteride syndrome is rare but serious and should be taken seriously.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Finasteride use may increase depression and suicide risk, especially at 1 mg, so monitoring is advised.

Agomelatine might help stop hair loss caused by valproate.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

A teenage girl's excessive hair growth was caused by a medication for mania, but improved after stopping the medication.

CGF and i-PRF are more effective and safer than PRP for treating female pattern hair loss.

Finasteride doesn't affect erections much, but may decrease libido in men.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

Finasteride is effective for hair regrowth, but some believe it may cause persistent symptoms due to psychological factors.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

Erianin may effectively treat alopecia areata by targeting the immune system.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

PRP shows promise in treating joint and spine issues, but translating lab results to humans is challenging.

Microneedling therapy leads to better treatment adherence than drug therapy for hair loss.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Finasteride helps brain function in rats with liver-related brain issues.